IBS - Irritable Bowel Syndrome Clinical Trial
Official title:
Evaluating the Impact of Including Virtual Dietary Education Within an Electronic Irritable Bowel Syndrome Pathway
NCT number | NCT05721742 |
Other study ID # | 53363 |
Secondary ID | |
Status | Recruiting |
Phase | N/A |
First received | |
Last updated | |
Start date | May 16, 2023 |
Est. completion date | March 2025 |
Verified date | May 2024 |
Source | Nova Scotia Health Authority |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Irritable bowel syndrome is a functional bowel disorder that affects many Canadians. The syndrome involves abdominal pain and change in frequency or form of bowel movements, and these symptoms can lead to a decreased quality of life for patients. Primary care physicians are dissatisfied with current referral processes, and patients may wait a long time to receive the correct diagnosis. Diet is known to exacerbate symptoms of IBS. In Canada, accessing dietary treatment for IBS is a challenge due to lack of resources. Some patients lack access to dietary interventions, and others are given advice that is not evidenced based. Use of eHealth technology, such as virtual education delivered by a dietician, may allow for more widespread access to dietary interventions for IBS. Virtual education can include one on one dietary education, online group-based education, and the use of apps. Currently, there is a gap in knowledge whether dietary intervention for IBS, delivered virtually by a dietician, is effective in treating IBS.
Status | Recruiting |
Enrollment | 76 |
Est. completion date | March 2025 |
Est. primary completion date | March 2025 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 65 Years |
Eligibility | Inclusion Criteria: - Recurrent abdominal pain on average at least 1 day/ week in the last 3 months associated with two or more of the following criteria: related to defecation, or association with a change in frequency of stool or associated with a change in form (appearance) of stool - Willingness to change diet - Access to a device for accessing virtual dietary education Exclusion Criteria: - New onset symptoms within past year in age 50 and above - Rectal bleeding - Inflammatory Bowel Disease - Unexplained recent weight loss - Gastrointestinal surgery with removal of gallbladder or segments of the bowel - Having an eating disorder |
Country | Name | City | State |
---|---|---|---|
Canada | QEII Health Sciences Centre | Halifax | N.S. |
Lead Sponsor | Collaborator |
---|---|
Nova Scotia Health Authority | Research Nova Scotia |
Canada,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | IBS Symptom Severity | IBS Symptom Severity as measured by the "IBS Symptom Severity Score". Minimum: 75, Maximum: >300. Mild, moderate and severe cases are indicated by scores of 75 to 175, 175 to 300 and > 300 respectively. | Baseline | |
Primary | IBS Symptom Severity | IBS Symptom Severity as measured by the "IBS Symptom Severity Score". Minimum: 75, Maximum: >300. Mild, moderate and severe cases are indicated by scores of 75 to 175, 175 to 300 and > 300 respectively. | 5 months post-randomization | |
Primary | IBS Specific Quality of Life | IBS Specific Quality of Life as measured by the "IBS Quality of Life Questionnaire". Minimum: 0, Maximum: 100. Higher scores indicating better IBS specific quality of life. | Baseline | |
Primary | IBS Specific Quality of Life | IBS Specific Quality of Life as measured by the "IBS Quality of Life Questionnaire". Minimum: 0, Maximum: 100. Higher scores indicating better IBS specific quality of life. | 5 months post-randomization | |
Primary | Patient Quality of Life | Patient Quality of Life as measured by the "EQ 5D 5L Questionnaire". This questionnaire comprises the following five dimensions (ie. five questions): mobility, self-care, usual activities, pain/discomfort and anxiety/depression. Each dimension (question) has 5 levels (possible answers): 1-no problems, 2-slight problems, 3-moderate problems, 4-severe problems and 5-extreme problems. The patient is asked to indicate his/her health state by ticking the box next to the most appropriate statement. This results in a 1-digit number that expresses the level selected for that dimension, and the digits for the five dimensions are combined into a 5-digit number that describes the patient's health state. There is also a visual analog scale which asks the patient to rate their overall health from 0-100, with 0 being the worst, and 100 being best possible health. | Baseline | |
Primary | Patient Quality of Life | Patient Quality of Life as measured by the "EQ 5D 5L Questionnaire". This questionnaire comprises the following five dimensions (ie. five questions): mobility, self-care, usual activities, pain/discomfort and anxiety/depression. Each dimension (question) has 5 levels (possible answers): 1-no problems, 2-slight problems, 3-moderate problems, 4-severe problems and 5-extreme problems. The patient is asked to indicate his/her health state by ticking the box next to the most appropriate statement. This results in a 1-digit number that expresses the level selected for that dimension, and the digits for the five dimensions are combined into a 5-digit number that describes the patient's health state. There is also a visual analog scale which asks the patient to rate their overall health from 0-100, with 0 being the worst, and 100 being best possible health. | 5 months post-randomization | |
Primary | Total number Inpatient services in the last 3 months | Total number of inpatient services (admissions) in the last 3 months the patient has received, using an adaptation of the Client Services Receipt Inventory (CSRI). The PI will create a questionnaire containing the Service Receipt (Section 4) questions of the CSRI. | Baseline | |
Primary | Total number Inpatient services in the last 3 months | Total number of inpatient services (admissions) in the last 3 months the patient has received, using an adaptation of the Client Services Receipt Inventory (CSRI). The PI will create a questionnaire containing the Service Receipt (Section 4) questions of the CSRI. | 5 months post randomization | |
Primary | Total number Outpatient appointments in the last 3 months | Total number of outpatient services (outpatient appointments) in the last 3 months the patient has received, using an adaptation of the Client Services Receipt Inventory (CSRI). The PI will create a questionnaire containing the Service Receipt (Section 4) questions of the CSRI. | baseline | |
Primary | Total number Outpatient appointments in the last 3 months | Total number of outpatient services (outpatient appointments) in the last 3 months the patient has received, using an adaptation of the Client Services Receipt Inventory (CSRI). The PI will create a questionnaire containing the Service Receipt (Section 4) questions of the CSRI. | 5 months post randomization | |
Primary | Volume of referrals to Dietician | Volume of referrals sent to the Virtual Dietician led 1 on 1 education session | 5 months post-randomization | |
Primary | Volume of referrals to Online Group Session | Volume of referrals sent to the online IBS group session, run by Happy Bellies Nutrition | 5 months post-randomization | |
Primary | Patient satisfaction with the Virtual Dietician led 1 on 1 education session | Patient satisfaction with the Virtual Dietician led 1 on 1 education session measured via questionnaires that were written by the study PI. The following statements will be presented, answers will follow a 5-point Likert scale where 1-strongly disagree 2-disagree 3-neutral 4-agree 5-strongly agree:
I feel confident managing my IBS Overall, I was satisfied receiving dietary education through telehealth It was easy to ask questions and get answers I felt comfortable communicating with the dietitian using the telehealth system It was easy to use the technology to access the services I had no concerns about the privacy of my personal data I would recommend this service to friends and family |
5 weeks post-randomization | |
Primary | Volume of 1 on 1 dietary consults completed | Volume of 1 on 1 dietary consults completed, records kept by study dieticians | 5 months post-randomization | |
Primary | Number of online modules competed for Online Group Session | Number of online modules competed for Online Group Session | 5 months post-randomization | |
Primary | Number of sessions compared to proposed | Number of virtual dietician led 1 on 1 education sessions compared to proposed | 5 months post-randomization | |
Primary | Number of Modules accessed | Number of Modules accessed for Online group session program run by Happy Bellies Nutrition | 5 months post-randomization | |
Primary | Number of Modules completed | Number of Modules completed for Online group session program run by Happy Bellies Nutrition | 5 months post-randomization | |
Primary | Percentage participation in group session | Percentage of participation for Online group session program run by Happy Bellies, Nutrition measured by how many participants contributed | 5 months post-randomization | |
Primary | Quality Adjusted Life Years | Quality adjusted life years as measured using the EQ 5D and client service receipt inventory | 5 months post-randomization |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT05118243 -
Innovative Tools to Produce Legume-based Foods for Increased Consumer Acceptance
|
N/A | |
Completed |
NCT04422327 -
The Impact of a Combination of Bifidobacterium Longum 35624® and 1714™ Strains in Adults With Irritable Bowel Syndrome
|
Phase 1/Phase 2 | |
Recruiting |
NCT05178017 -
Lifestyle Eating and Performance (LEAP) Program for the Treatment of Irritable Bowel Syndrome (IBS)
|
N/A | |
Completed |
NCT05197413 -
Study to Evaluate the Efficacy of Arrae's Bloat & Calm Alchemy Capsules to Reduce Bloating, Heartburn and Gas, and Alleviate the Intensity of IBS Symptoms
|
N/A | |
Completed |
NCT04905524 -
Activity Changes in Irritable Bowel Syndrome (IBS), Anxiety, and Depression Following the Use of Viome Precision Nutrition Program (VPNP)
|
N/A | |
Recruiting |
NCT06297785 -
Online, Gut-directed Hypnotherapy for Patients With Irritable Bowel Syndrome (IBS)
|
N/A | |
Recruiting |
NCT05874830 -
The Optimal Route of Fecal Microbiota Transplantation for Irritable Bowel Syndrome
|
N/A | |
Active, not recruiting |
NCT04723056 -
Zemedy Application for Irritable Bowel Syndrome
|
N/A | |
Completed |
NCT05565612 -
Clinical Trial to Evaluate the Effect of a Probiotic Mixture on Signs and Symptoms of Irritable Bowel Syndrome
|
N/A | |
Recruiting |
NCT03131414 -
The IMAGINE-SPOR CIHR Chronic Disease Network
|
||
Completed |
NCT03333291 -
Fecal Transplantation in Patients With IBS
|
N/A | |
Completed |
NCT03449628 -
L. Casei DG® in Patients With Irritable Bowel Syndrome.
|
N/A | |
Recruiting |
NCT06215222 -
Capsule Microbiota Sampling in IBS/Functional Gastrointestinal Disease
|
||
Completed |
NCT05016596 -
Postprandial Lipids in IBS and Nutritional Treatment
|
N/A | |
Recruiting |
NCT04760353 -
The Effect of a Probiotic Mixture in Obese Patients With Irritable Bowel Syndrome
|
N/A | |
Completed |
NCT06426745 -
Split-dose Versus Single-dose Bowel Preparation for Colonoscopy
|
N/A | |
Recruiting |
NCT04217733 -
Ethosuximide and Pentoxifylline in the Treatment of Abdominal Pain Related to Irritable Bowel Syndrome
|
Phase 3 | |
Completed |
NCT03178877 -
The Prevalence of Irritable Bowel Syndrome Using Rome IV Criteria in Medical Student and The Related Factors
|
N/A | |
Recruiting |
NCT05990764 -
Effects of a Combination of Polyphenol-rich Extracts, Prebiotics, and Hydrolyzed Fiber on the Quality of Life of Patients With Irritable Bowel Syndrome (IBS)
|
N/A | |
Completed |
NCT03948854 -
Implementing a Low FODMAP Diet in Irritable Bowel Syndrome Patients
|
N/A |